The Board of Directors of Mindesta Inc. announced the appointment of Gilles Derome and Dr. Dana Allen as Advisory Board members of the firm - CTT Pharmaceuticals, effective immediately. Gilles Derome brings more than twenty-five years of marketing-sales and senior management experience in pharmaceuticals combined with consulting for bio-pharmaceutical companies. Through his pharmaceutical career at Sandoz/Novartis, Gilles had the opportunity to launch several products spanned over different therapeutic areas such as immunology, oncology, neurology, asthma, cardiovascular, mental health and women health.

During his tenure as Head of Scientific Development, Gilles had the pre-marketing responsibility for the entire company's portfolio ensuring proper products positioning, pricing and reimbursement strategy to accelerate market penetration. Dr. Dana Allen, most recently served as Chair of the Department of Clinical Studies of the Ontario Veterinary College and in the past served as Chair of the Department of Companion Animals of the Atlantic Veterinary College.